Pharmaceutical Company Invests in Beihui Bio-Peak Pharmaceutical Plate to Expand its Territory
Release time:
2020-07-31
News from this newspaper 2# March 28 , the 10 meeting of the ninth board of directors of the group company deliberated and passed the "Proposal on Foreign Investment of Subsidiaries" and the "Proposal on Authorizing the Chairman". On the same day, Jianfeng Pharmaceutical signed the "Agreement on Capital Increase and Share Transfer of Beijing Huibaoyuan Biotechnology Co., Ltd." and the "Performance Commitment Compensation Agreement" with relevant parties. It is planned to use Beijing Huibaoyuan Biotechnology Co., Ltd. (Beihui Biotechnology) and its holding subsidiary Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. (Guanghui Pharmaceutical) as a platform to jointly carry out new drug research and development, drug production and operation and other pharmaceutical business cooperation.
Beihui Biology was formerly known as Beijing Huibaoyuan Biotechnology Co., Ltd. The company has strong capabilities in new drug research and development. The actual controller is James Zhou (Zhou Hua), a returned entrepreneurial Ph.D. from Yale University in the United States, and hired Professor Zheng Yongqi from Yale University in the United States as the director of the Huibaoyuan Science and Technology Committee, focusing on anti-tumor and liver disease research. Through cooperation with Yale University, we have obtained patent authorization and commercial development license for the new anticancer chemical drug troxacitabine (trokacitabine )(the national clinical approval for the new drug has been obtained in 2016 ), the anti-hepatitis B chemical drug clevudine (Clevudine ).
Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd., a subsidiary of Beihui Biological Holding Company, is located in the third international park "China-Malaysia Qinzhou Industrial Park" jointly established by the Chinese government and foreign governments in Guangxi. It covers an area of 214.46 mu and has basically completed the production workshops of percolation, tincture, solid preparation, liquid preparation and other dosage forms, at present, it has entered the GMP certification stage. Guanghui Pharmaceutical has 77 drug approvals mainly for proprietary Chinese medicine preparations. Its main products include Huoxiang Zhengqi Water, Shidishui, Chen Xianglu Bailu Tablets, Compound Pearl Jiedu Oral Liquid, Yigan Mingmu Oral Liquid, etc. Among them, Yigan Mingmu Oral Liquid and Pearl Jiedu Oral Liquid are exclusive products.
According to the cooperation agreement, when the agreed preconditions are met, Jianfeng Pharmaceutical plans to increase the capital of Beihui Biology in four phases. After the agreement comes into effect, it will make the first phase of investment and will contribute ,000 yuan to increase the capital of Beihui Biology in 2,000 shares (accounting for 20% of shares); the second phase contributed ,8600 yuan to increase ,2000 shares of Beihui Biology, and at the same time contributed ,3010 yuan to transfer ,700 shares of Beihui Biology. In the third and fourth phases, the capital increase was ,1400 shares respectively. The capital increase price was determined through negotiation based on the evaluation value of Beihui Biology at that time. If the capital increase and equity transfer are all completed, Peak Pharmaceuticals will hold Beihui Bio 7500 shares (accounting for 50.68% of the equity, the calculation of the equity ratio does not take into account the introduction of other investors). The next few phases of investment will be implemented in stages according to the investment prerequisites agreed in the agreement, the progress of product development, the operation of the target company and other factors.
This cooperation is based on the company's strategic policy of "cooperating and innovating to strengthen the main business, standardizing science and seeking development". It is the specific implementation of expanding and strengthening the pharmaceutical business, which will help to further enhance the new drug research and development capability of Jianfeng Pharmaceutical and further expand the scale of the company's pharmaceutical business. (Zhou Hengbin)
More information
Peak health marketing and a new "play"
Building a New System, Flattening Management, Spike Health Marketing, New "Way to Work" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original business model, unifies all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)
2020
07-30
2020
07-30
2020
07-31
2020
07-31
On January 23, the group company held a special working meeting to summarize the safety and environmental protection work in 2016 and make arrangements for the work in the new year. General manager Yu Jianhong pointed out at the meeting that hidden dangers are accidents, accidents should be assessed, and safety and environmental protection work should continue to be carried out with a "zero tolerance" attitude. At the meeting, Chen Tianci, assistant to the general manager of the group company and manager of the audit performance management department, summarized the safety and environmental protection work in 2016 from the aspects of the completion of the safety and environmental protection responsibility system objectives, self-examination and self-correction of illegal operations, and the establishment of safety and environmental protection accident-free factories, analyzed the problems existing in the work, and put forward the safety and environmental protection work plan for 2017 in a targeted manner. Jiang Xiaomeng, chairman of the group company, stressed at the meeting that the work of safety and environmental protection is endless and must be carried out unremittingly. All enterprises should focus on safety and environmental protection management in a planned and focused manner according to the characteristics of their respective industries and industries, seasonal changes, and national policy adjustments. It is more important to establish awareness than inspection. It is necessary to strengthen safety and environmental protection education and improve the safety and environmental protection awareness and related work skills of all employees. Conduct in-depth pre-inspection and strict post-assessment to achieve full management and comprehensive prevention, and realize the overall improvement of enterprise safety and environmental protection. At the meeting, Jiang Xiaomeng, on behalf of the group company, signed the 2017 safety and environmental protection work responsibility letter with various professional companies and directly affiliated enterprises. In his concluding speech, Yu Jianhong, general manager of the group company, pointed out that safety runs through the development of the enterprise, and safety and environmental protection cannot be separated from production and operation. The two promote each other and complement each other, and managers at all levels must have a deep level of this.
2020
07-31
"Spike" Cement Becomes Yunnan Famous Brand Product
News from our newspaper At the beginning of the new year, good news came from Yunnan Jianfeng Cement Company. The "Jianfeng" brand cement successfully passed the examination and approval and won the title of "Yunnan Famous Brand Product. Since it was put into production in 2013, the "Jianfeng" brand cement produced by Yunnan Jianfeng has won good sales performance and reputation in the southwest Yunnan market, and its popularity and brand influence have been continuously improved. Therefore, Yunnan Jianfeng started to declare "famous brand products" in 2016. After preliminary data preparation, preliminary examination by Pu'er Municipal Bureau of Quality and Technical Supervision, expert review by Yunnan Provincial Bureau of Quality and Technical Supervision and on-site verification, Yunnan Provincial Bureau of Quality and Technical Supervision finally passed the examination and approval of "Yunnan Famous Brand Products" organized by Yunnan Provincial Strategic Leading Group for Implementing Brand and Strong Quality Province in 2017. The acquisition of this honorary title will further enhance the market competitiveness of Jianfeng Cement in southwestern Yunnan, and also increase the popularity of Yunnan Jianfeng, laying a more solid foundation for further market development in the future. (Li Chun)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page